| Date | Title | Description | |
|---|---|---|---|
| 05 Nov 2021 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted on 3 and 4 November | Download |
| 03 Nov 2021 | On business and financial situation | The Company releases the first nine months 2021 financial results presentation | Download |
| 03 Nov 2021 | On business and financial situation | The Company releases the press release related to the first nine months 2021 financial results | Download |
| 21 Oct 2021 | Liquidity and counterparty agreements | Download | |
| 21 Oct 2021 | On business and financial situation | The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 29 Apr 2015 | Otros sobre Gobierno Corporativo | Download | |
| 26 Feb 2015 | Información sobre resultados (2) | Download | |
| 26 Feb 2015 | Información sobre resultados | Download | |
| 26 Feb 2015 | Informe anual de remuneraciones de los consejeros | Download | |
| 26 Feb 2015 | Composición del Consejo de Administración | Download |